Zincoderm Cream contains Clobetasol 0.05% w/w, a potent topical corticosteroid indicated for the management of various inflammatory and pruritic dermatoses, including psoriasis, eczema, and lichen planus. Clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing erythema, swelling, and itching. Zincoderm Cream is intended for short-term use due to its high potency, and should be applied sparingly to the affected areas once or twice daily as directed by a healthcare professional. Prolonged or excessive use may lead to adverse effects such as skin atrophy, telangiectasia, and systemic absorption potentially causing hypothalamic-pituitary-adrenal axis suppression. It is contraindicated in patients with hypersensitivity to clobetasol or any component of the formulation, as well as in untreated bacterial, viral, or fungal skin infections. Caution is advised when used on large surface areas, broken skin, or in pediatric populations. Patients should avoid occlusive dressings unless prescribed, and discontinue use if irritation or hypersensitivity reactions occur. Zincoderm Cream should be stored at controlled room temperature, away from direct light and moisture. Consultation with a healthcare provider is recommended before initiating therapy to ensure appropriate use and monitoring.